In B-cell lymphoma, inhibition of HDAC3 was shown to upregulate PD-L1 transcription [183], and in another study on lung cancer in mice, inhibition of HDAC6 was shown to decrease PD-L1 mRNA and protein levels [184]. This evidence concerns the gene CD274 and B-cell non-Hodgkin lymphoma.